Claim Rates Identified for Musculoskeletal Disorders From Overexertion
The rate of work-related musculoskeletal disorder (WMSD) claims from overexertion among construction workers is highest for those aged 35 to 44 years.
Musculoskeletal Disorders
Supporting Adolescent Rheumatic Patients’ Mental Health: 5 Issues of Concern
Adolescent patients with chronic rheumatic disease can be at risk for mental health issues that could cause a lower quality of life and impact their illness. What are some of these concerns?
Osteoarthritis Management Guidelines
An evidence-based guideline for the comprehensive management of osteoarthritis , including educational, behavioral, psychosocial, and physical interventions, as well as pharmacologic therapies from the American College of Rheumatology (ACR) and the Arthritis Foundation.
FDA Approves 3D Printed Implant for Avascular Necrosis of the Talus
The FDA has approved the Patient Specific Talus Spacer for humanitarian use in the treatment of avascular necrosis of the ankle joint.
Gout Treatments
Gout treatment chart for acute attacks or chronic management/prevention.
Global Burden High for Musculoskeletal Disorders
The global burden of musculoskeletal disorders is considerable, but prevalence and DALYs have decreased slightly since 1990.
Let’s Talk Women’s Health in Rheumatic Diseases
In this episode, we’re highlighting the importance of recognizing and discussing women’s health – from premenstruation through menstruation and pregnancy and menopausal transition – in rheumatology.
Self-Reported Frailty Prevalent Among Patients With Rheumatic Musculoskeletal Diseases
Researchers described the prevalence of self-reported frailty among patients with rheumatic musculoskeletal diseases and its associated factors.
Orphenadrine and Aspirin Combination Now Available for Pain Management
Orphengesic Forte for the symptomatic relief of mild to moderate pain of acute musculoskeletal disorders is now available.
FDA Approves Orphenadrine and Aspirin Combination for Pain Management
The FDA has approved the supplemental Abbreviated New Drug Application (sANDA) for Orphengesic Forte.
- Loading...
Loading...
Next post in Pain Management
Loading... 
Loading...